Predicting how a biotherapeutic will behave in humans is a critical step in drug design —but it's far from straightforward. While nonclinical models can help foresee certain negative effects, they often fall short when it comes to immunotoxicity and other immune-related reactions. With the growing
Technology and science are constantly evolving and advancing, and with them, the world of drug development is also changing. Using AI and CRISPR for gene editing and bioprinting human-like tissues are just some examples of innovations that are set to change how life-saving therapies are developed.
The biopharmaceutical industry is undergoing rapid transformation due to the rising popularity of cell and gene therapy for various cancer conditions, some uncommon diseases, and degenerative conditions, as traditional drugs and biological products show limited success. The field is now moving to
The biotech industry in particular will experience high levels of uncertainty and changes in 2025. Emerging biotech companies are facing significant challenges due to new technologies, intense global competition, and changes in the market. Next year, 2025, may be tough for startups as they
The life sciences industry has come a long way since the last COVID-19 outbreak. Today, organizations are prioritizing efficiency, speed, and innovation. That’s why biopharma and biotech companies are increasingly broadening their investments in physical spaces. Campuses and facilities are being
The global brain-computer interface (BCI) market is expected to grow from USD $2.1 million in 2022 to USD $9.4 million by 2032, with a growth rate of 16.7% from 2023 to 2032. This exciting area of research and development can create a direct communication link between the human brain and devices
